Single-vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need

JAMA - Journal of the American Medical Association

Volumn 313, Issue 9, 2015, Pages 936-948

  Schaffer, Justin M ^a   Singh, Steve K ^b,c   Reitz, Bruce A ^a   Zamanian, Roham T ^d   Mallidi, Hari R ^b,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOUBLE LUNG TRANSPLANTATION; EXPLORATORY RESEARCH; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETRANSPLANTATION; SINGLE LUNG TRANSPLANTATION; UNITED STATES; AGED; COMPARATIVE STUDY; HEALTH CARE ORGANIZATION; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN MEIER METHOD; MORTALITY; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROPENSITY SCORE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSPLANTATION;

ADULT; AGED; GRAFT SURVIVAL; HEALTH CARE RATIONING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MIDDLE AGED; PROPENSITY SCORE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TISSUE AND ORGAN PROCUREMENT; UNITED STATES;

EID: 84924452572     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.1175     Document Type: Article

References (43)

1. Colvin-Adams M, Valapour M, Hertz M, et al. Lung and heart allocation in the United States. Am J Transplant. 2012;12(12): 3213-3234.
2. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(5 pt 2): 1212-1227.
3. Eberlein M, Garrity ER, Orens JB. Lung allocation in the United States. Clin Chest Med. 2011;32(2): 213-222.
4. Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135(4): 923-928.
5. Yusen RD, Shearon TH, Qian Y, et al. Lung transplantation in the United States, 1999-2008. Am J Transplant. 2010;10(4 pt 2): 1047-1068.
6. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med. 2011;184(2): 159-171.
7. Christie JD, Edwards LB, Kucheryavaya AY, et al; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31(10): 1073-1086.
8. Thabut G, Christie JD, Ravaud P, et al. Survival after bilateral vs single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet. 2008;371(9614): 744-751.
9. Thabut G, Christie JD, Ravaud P, et al. Survival after bilateral vs single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med. 2009;151(11): 767-774.
10. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25): 3083-3107.
11. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1): 43-46.
12. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J AmStat Assoc. 1958;53: 457-481.
13. Austin PC. The use of propensity scoremethods with survival or time-To-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7): 1242-1258.
14. Bland JM, Altman DG. The logrank test. BMJ. 2004;328(7447): 1073.
15. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75(1): 45-49.
16. Thabut G, Christie JD, Kremers WK, Fournier M, Halpern SD. Survival differences following lung transplantation among US transplant centers. JAMA. 2010;304(1): 53-60.
17. Tsuang WM, Vock DM, Finlen Copeland CA, Lederer DJ, Palmer SM. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med. 2013;158(9): 650-657.
18. Centers for Disease Control and Prevention. Guidelines for Preventing Transmission of Human Immunodeficiency Virus Through Transplantation of Human Tissue and Organs. http://wonder.cdc.gov/wonder/prevguid/m0031670/m0031670.asp. Accessed December 10, 2014.
19. Therneau TM, Grambsch PM, Pankratz VS. Penalized survival models and frailty. J Comput Graph Stat. 2003;12(1): 156-175.
20. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4): 377-399.
21. Marshall A, Altman DG, Royston P, Holder RL. Comparison of techniques for handlingmissing covariate data within prognostic modelling studies: a simulation study. BMC Med ResMethodol. 2010; 10: 7.
22. White IR, Royston P. Imputingmissing covariate values for the Cox model. Stat Med. 2009;28(15): 1982-1998.
23. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3): 206-213.
24. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70: 41-55.
25. Tan Z. Bounded, efficient and doubly robust estimation with inverse weighting. Biometrika. 2010;97(3): 661-682.
26. Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1): 1-21.
27. Cox DR. Regression models and life-Tables. J R Stat Soc Series B StatMethodol. 1972;34(2): 187-220.
28. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3): 515-526.
29. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15): 2175-2197.
30. Hosmer DW, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time-To-Event Data. 2nd ed. Hoboken, NJ: Wiley Interscience; 2008.
31. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19 (6): 716-723.
32. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1): 125-137.
33. Valapour M, Paulson K, Smith JM, et al. OPTN/SRTR 2011 annual data report: lung. Am J Transplant. 2013;13(suppl 1): 149-177.
34. King CS, Khandhar S, Burton N, et al. Native lung complications in single-lung transplant recipients and the role of pneumonectomy. J Heart Lung Transplant. 2009;28(8): 851-856.
35. SchwaiblmairM, Reichenspurner H, Müller C, et al. Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med. 1999;159(4 pt 1): 1277-1283.
36. Williams TJ, Snell GI. Early and long-Term functional outcomes in unilateral, bilateral, and living-related transplant recipients. Clin Chest Med. 1997;18(2): 245-257.
37. Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg. 2005;79(3): 950-957.
38. Whelan TP, Dunitz JM, Kelly RF, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant. 2005; 24(9): 1269-1274.
39. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant. 2001;20(9): 935-941.
40. Lederer DJ, Kawut SM, Wickersham N, et al; Lung Transplant Outcomes Group. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011;184(9): 1055-1061.
41. Allen JG, Weiss ES, Merlo CA, BaumgartnerWA, Conte JV, Shah AS. Impact of donor-recipient race matching on survival after lung transplantation: analysis of over 11, 000 patients. J Heart Lung Transplant. 2009;28(10): 1063-1071.
42. Eberlein M, Reed RM, Maidaa M, et al. Donor-recipient size matching and survival after lung transplantation: a cohort study. Ann Am Thorac Soc. 2013;10(5): 418-425.
43. Eberlein M, Diehl E, Bolukbas S, Merlo CA, Reed RM. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension. J Heart Lung Transplant. 2013;32(12): 1172-1178.